What is the percentage risk of acquiring a sexually transmitted infection from receiving oral sex (fellatio) from a high‑risk partner?

Risk of STI Transmission from Receptive Fellatio with High-Risk Partner

The per-act risk of acquiring HIV from receptive fellatio (receiving oral sex) is approximately 0.04% (4 per 10,000 exposures), which is substantially lower than vaginal intercourse (0.1–0.2%) or receptive anal intercourse (0.5–3%), though other STIs including gonorrhea, chlamydia, syphilis, and herpes can be transmitted more efficiently through oral sex. 1

HIV Transmission Risk

• The CDC estimates the baseline per-act HIV transmission risk from receptive fellatio at 0.04% when the partner is HIV-positive or of unknown status, making it one of the lowest-risk sexual exposures 1, 2
• A prospective cohort study of 2,189 high-risk MSM confirmed this estimate, finding a per-contact risk of 0.04% for receptive oral sex with HIV-positive or unknown-status partners 2
• Among 239 MSM who practiced exclusively fellatio, no HIV infections were detected despite 50% having three or more partners and 28% having HIV-positive partners, yielding a population-attributable risk of only 0.10–0.31% 3

Critical Risk Modifiers That Increase HIV Transmission

The following factors can substantially elevate the baseline 0.04% risk:

• Ejaculation in the mouth delivers a larger viral inoculum than pre-ejaculate exposure and is the primary determinant of transmission risk, not the duration of contact 1
• Oral lesions, bleeding gums, or ulcers create direct entry points for HIV and markedly increase acquisition probability 1
• High viral load in the source partner (i.e., not virally suppressed on antiretroviral therapy) amplifies transmission risk across all exposure types 1
• Concurrent genital ulcerative STIs (herpes, syphilis) in the source partner increase viral shedding 1
• Trauma or bleeding during the sexual act further elevates risk 1

Other Bacterial STI Risks

Gonorrhea and chlamydia are transmitted far more efficiently through oral sex than HIV:

• Triple-site screening (urine, pharyngeal, rectal) in MSM living with HIV detected 24.4% with chlamydia and 26.7% with gonorrhea, compared to only 6.7% detection when urine alone was tested 4
• This indicates that pharyngeal gonorrhea and chlamydia are common in high-risk populations and frequently asymptomatic 4
• Oral-genital transmission of these pathogens occurs readily in both directions (giving and receiving oral sex) 4

Syphilis Transmission Risk

• Syphilis transmission through oral sex occurs when direct contact is made with infectious oral or genital lesions (primary or secondary syphilis) 5
• The spirochete Treponema pallidum requires direct mucosal contact with lesions for efficient transmission; blood-only exposure (as in needlestick) carries negligible risk 5
• In the MSM cohort followed over 28 months, syphilis seropositivity increased from 18% to 34%, indicating ongoing transmission in high-risk networks 4

Herpes Transmission Risk

• HSV-1 from oral secretions frequently causes genital herpes through oro-genital contact, and the traditional HSV-1 (oral) versus HSV-2 (genital) distinction no longer holds 6
• Transmission occurs when visible oral lesions are present, though asymptomatic viral shedding can also transmit infection 6
• Primary HSV-1 genital infection in a seronegative person causes severe genital lesions with a 2–10 day incubation period 6

Post-Exposure Management Algorithm

For HIV Exposure (Ejaculation in Mouth from Known HIV+ Partner)

1. Initiate PEP immediately (ideally within 24 hours, no later than 72 hours) with a 28-day course of combination antiretroviral therapy 1
2. The CDC classifies oral exposure to ejaculate from an HIV-positive source as a "substantial risk for HIV exposure" warranting PEP 1
3. PEP effectiveness declines sharply after 72 hours 1
4. Perform baseline HIV testing, then repeat at 6 weeks, 3 months, and 6 months 1

For Other STI Exposures

• No validated post-exposure prophylaxis exists for gonorrhea, chlamydia, syphilis, or herpes 6
• Monitor for symptoms over the next 2–10 days (herpes incubation) 6
• Seek immediate evaluation if genital or oral lesions develop for viral culture or PCR testing 6
• Triple-site STI screening (urine, pharyngeal, rectal) should be performed at baseline and repeated at 3–6 months, as single-site testing misses the majority of infections 1, 4

Prevention Strategies

• Viral suppression in HIV-positive partners through antiretroviral therapy reduces transmission risk by approximately 96% across all exposure types 1
• Pre-exposure prophylaxis (PrEP) is advised for individuals with repeated high-risk exposures 1
• Avoid all sexual contact when visible oral lesions are present to prevent herpes transmission 6
• Condoms reduce but do not eliminate HSV transmission risk, as they may not cover all infectious areas 6
• Regular STI screening every 3–6 months is recommended for sexually active persons in high-risk networks 1

Common Pitfalls

• Relying on urine-only testing misses 73% of gonorrhea and chlamydia infections in MSM, as pharyngeal and rectal sites are the primary infection sites 4
• Focusing on HIV risk alone underestimates the substantially higher risk of bacterial STIs and herpes from the same exposure 6, 4
• Delaying PEP initiation while awaiting source partner testing reduces effectiveness; start immediately if indicated and discontinue if source tests negative 1